To Study Of The Effect Of Tranexamic Acid And Oxytocin Versus Oxytocin Alone On Blood Loss Immediately After Placental Delivery In Patients Beyond 37 Weeks of Gestation After Vaginal Delivery In CRH

A Comparative Study Of The Efficacy Of Tranexamic Acid And Oxytocin Versus Oxytocin Alone On Blood Loss Immediately After Placental Delivery In Patients Beyond 37 Weeks of Gestation After Vaginal Delivery In CRH Over a Period Of 1 Year - NILL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057379

Enrollment

160

Registered

2023-09-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Inj tranexamic acid along iv with inj oxytocin iv: patient will be divided into 2 groups , group A and group B . Group A will be getting Inj tranexamic 1g iv along with inj oxytocin 1

Eligibility

Inclusion criteria

Inclusion criteria: All antenatal pregnant female in labour beyond 37 week of period of gestation

Exclusion criteria

Exclusion criteria: 1.one who doesn’t give consent to participate in this study 2.Multiple Pregnancy 3.Coagulation disorders. 4.All High risks pregnancy(hypertension,diabetes,Antepartum haemorrhage).

Design outcomes

Primary

Measure	Time frame
to assess effect of tranexamic acid on blood loss after vaginal deliveryTimepoint: day 0 and day 2	—

Secondary

Measure	Time frame
determine effect of early administration of tranexamic acid on mortality/hysterectomy/other morbidities like- surgical intervention,blood transfusion, risk of non-fatal vascular events in women clinically diagnosed with PPH Timepoint: before delivery & 48 hours of delivery	—

Countries

India

Contacts

Public ContactDr Anup Pradhan

Sikkim Manipal Institute Of Medical Sciences

anup.p@smims.smu.edu.in9434485334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026